State Street Corp Isoray, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	910,900 Added 135.65%	1,582,424 $1.09 Million
Q3 2023 Nov 14, 2023	BUY	N/A	21,100 Added 3.24%	671,524 $463,000
Q2 2023 Aug 14, 2023	BUY	$0.0 - $0.69 $0 - $66,795	96,805 Added 17.49%	650,424 $448,000
Q1 2022 May 16, 2022	BUY	$0.31 - $0.41 $10,718 - $14,176	34,577 Added 6.66%	553,619 $201,000
Q2 2021 Aug 16, 2021	BUY	$0.75 - $1.15 $381,348 - $584,734	508,465 Added 4807.27%	519,042 $414,000
Q1 2020 May 11, 2020	BUY	$0.53 - $0.99 $5,605 - $10,471	10,577 New	10,577 $6,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.